首页> 美国卫生研究院文献>Microsystems Nanoengineering >Branched hybridization chain reaction—using highly dimensional DNA nanostructures for label-free reagent-less multiplexed molecular diagnostics
【2h】

Branched hybridization chain reaction—using highly dimensional DNA nanostructures for label-free reagent-less multiplexed molecular diagnostics

机译:分支杂交链反应-使用高维DNA纳米结构进行无标记无试剂的多重分子诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The specific and multiplexed detection of DNA underpins many analytical methods, including the detection of microorganisms that are important in the medical, veterinary, and environmental sciences. To achieve such measurements generally requires enzyme-mediated amplification of the low concentrations of the target nucleic acid sequences present, together with the precise control of temperature, as well as the use of enzyme-compatible reagents. This inevitably leads to compromises between analytical performance and the complexity of the assay. The hybridization chain reaction (HCR) provides an attractive alternative, as a route to enzyme-free DNA amplification. To date, the linear nucleic acid products, produced during amplification, have not enabled the development of efficient multiplexing strategies, nor the use of label-free analysis. Here, we show that by designing new DNA nanoconstructs, we are able, for the first time, to increase the molecular dimensionality of HCR products, creating highly branched amplification products, which can be readily detected on label-free sensors. To show that this new, branching HCR system offers a route for enzyme-free, label-free DNA detection, we demonstrate the multiplexed detection of a target sequence (as the initiator) in whole blood. In the future, this technology will enable rapid point-of-care multiplexed clinical analysis or in-the-field environmental monitoring.
机译:DNA的特异性和多重检测是许多分析方法的基础,包括医学,兽医和环境科学中重要微生物的检测。为了实现这样的测量,通常需要酶介导的存在的低浓度靶核酸序列的扩增,以及对温度的精确控制,以及使用酶相容性试剂。这不可避免地导致分析性能和测定复杂性之间的折衷。杂交链反应(HCR)提供了一种有吸引力的替代方法,可作为无酶DNA扩增的途径。迄今为止,扩增过程中产生的线性核酸产物尚未能开发出有效的多路复用策略,也未使用无标记分析。在这里,我们表明,通过设计新的DNA纳米结构,我们首次能够提高HCR产品的分子尺寸,从而创建高度分支的扩增产物,可以在无标记传感器上轻松检测到。为了证明这个新的分支HCR系统为无酶,无标记的DNA检测提供了一条途径,我们展示了全血中靶序列(作为引发剂)的多重检测。将来,该技术将支持快速的即时医疗点多重临床分析或现场环境监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号